New allergy vaccine for hay fever shows promising results
Using sugar molecules, researchers from the University of Copenhagen have developed a new vaccine for hay fever that may reduce […]
TOKYO and CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and […] As in the case of a major stroke, in a transient ischemic attack (TIA), or mini-stroke, blood supply to the […]results
Eisai and Biogen Announce Detailed Results of Phase II Clinical Study of BAN2401 in Early Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2018
Stroke: Clinical trial results ‘likely to change care practice’